CG
KITE

Cutler Group’s Kite Pharma, Inc. KITE Stock Holding History

Cutler Group’s Portfolio KITE Stock Details KITE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		– Sell
-90,200
Closed -$3K – 6649
2017
Q3 		$3K Buy
90,200
+19,300
+27% +$2.69M ﹤0.01% 4970
2017
Q2 		$116K Buy
70,900
+28,800
+68% +$2.35M ﹤0.01% 1735
2017
Q1 		$196K Sell
42,100
-7,600
-15% -$470K 0.01% 1213
2016
Q4 		$159K Sell
49,700
-8,200
-14% -$402K 0.01% 1495
2016
Q3 		$107K Buy
57,900
+38,100
+192% +$2.12M ﹤0.01% 1753
2016
Q2 		$121K Sell
19,800
-6,600
-25% -$324K 0.01% 1533
2016
Q1 		$236K Sell
26,400
-5,300
-17% -$257K 0.02% 917
2015
Q4 		$176K Buy
+31,700
New +$2.23M 0.01% 1290

Cutler Group's KITE Position: Q4 2017 in Review

Cutler Group sold out of Kite Pharma, Inc. (KITE) in Q4 2017, closing a stake of 4,684 shares — an estimated $842K sold.

Cutler Group first reported a position in KITE in Q4 2015 and held it in 8 quarters. The position peaked at $969K in Q2 2017. 0 funds tracked by Wall St. Rank hold KITE as of Q4 2017.

  • Cutler Group reported no remaining Kite Pharma, Inc. position as of Q4 2017 after selling out during the quarter.
  • Cutler Group sold 4,684 Kite Pharma, Inc. shares in Q4 2017, an estimated $842K.
  • Cutler Group first reported a position in Kite Pharma, Inc. in Q4 2015 and held it in 8 quarters.
  • Cutler Group's Kite Pharma, Inc. position peaked at $969K in Q2 2017.
  • 0 funds tracked by Wall St. Rank held Kite Pharma, Inc. as of Q4 2017.

Based on Cutler Group's 13F filing for Q4 2017, filed 17 Jan 2018.